![]() |
市场调查报告书
商品编码
1847170
全球髓内钉市场:市场规模、份额和趋势分析(2025-2031 年)Intramedullary Nails Market Size, Share, & Trends Analysis | Global | 2025-2031 | Includes: Humeral Intramedullary Nails, Forearm Intramedullary Nails, and 2 more |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2024年全球髓内钉(IM)市值为12亿美元。预计该市场将持续成长,到2031年将达到15亿美元。
本报告涵盖全球髓内钉市场的所有产品细分领域,包括肱骨、前臂、股骨、胫骨和踝关节髓内钉。报告量化了销量、平均售价 (ASP)、市场规模、成长率和企业市场占有率。此外,报告还分析了市场驱动因素、限制因素、手术量、近期併购以及技术趋势。本研究提供了截至 2021 年的历史资料以及截至 2031 年的预测资料。
市场概览
髓内钉固定是整形外科创伤固定的基石,尤其治疗方法长骨骨折的治疗。与传统的钢板固定係统相比,髓内钉固定能够在髓腔内实现内部稳定,从而实现更早期的活动和更佳的负荷分布。过去十年,髓内钉固定已成为股骨和胫骨骨折的首选治疗方法,其应用范围也扩展到肱骨和踝关节。
外科技术的进步和植入设计的创新使髓内钉成为创伤治疗的重要组成部分。製造商不断改进髓内钉的形状、锁定机制和手术器械,以提高其插入的便利性、对位精度和动态性能。这些进步有助于缩短手术时间、减少併发症并改善临床疗效。
儘管已开发地区的髓内钉市场竞争激烈且已趋于成熟,但由于创伤治疗的可及性提高,新兴市场的需求正在迅速增长。全球人口老化、骨质疏鬆性骨折病例增加以及道路交通事故导致的高能量损伤增多,都推动了全球对该手术的需求。
除了创伤修復外,肢体延长和畸形矫正术也正在成为新兴的成长领域。随着企业将业务拓展到传统骨折固定之外,专用的髓内固定係统正在被开发用于非创伤性适应症。这些应用利用髓内钉的动态特性来实现可控的骨骼延长和骨骼復位,为整形外科手术开闢了新的可能性。
整体而言,髓内钉市场正透过渐进式设计创新、更精密的器械和改进的材料不断发展。这些趋势预计将支撑市场在强劲的手术需求推动下保持温和成长,但同时也受到价格压力和其他固定方法的竞争的限制。
市场驱动因素
良好的临床结果
在长骨骨折治疗中,髓内钉始终展现出优于钢板螺丝的动态稳定性和承重能力。其负荷分担设计允许早期活动,从而降低关节挛缩和肌肉萎缩的风险。这一特性在股骨和胫骨骨折中尤其重要,因为早期復健对长期功能恢復至关重要。
在需要持久固定的病例中,外科医生更倾向于使用髓内钉,尤其是在轴向和扭转稳定性至关重要的情况下。术后效果的改善,包括术后併发症的减少(感染率降低、对位更佳、住院时间更短),增强了临床医师对髓内钉系统的信心。这些优点持续推动着髓内钉在主要解剖部位的广泛应用。
设备改进
虽然髓内钉本身的结构相对标准化,但竞争的差异化已转移到器械设计。现代内固定髓内钉系统强调符合人体工学和操作简单的器械,以简化手术流程。
製造商正致力于研发定位装置、扩孔工具和锁定机构,以提高手术精度,同时最大限度地减少辐射曝射量和手术时间。简化的定位导引装置可降低错位风险,而整合的深度和角度控制则可提高螺丝植入的准确性。
器械系统的持续更新是影响外科医师偏好和品牌忠诚度的关键因素。随着手术效率对购买决策的影响日益增强,提供全面、易用系统的公司将获得竞争优势。
踝关节髓内钉的生长
在所有解剖适应症中,踝关节髓内钉固定术是成长最快的领域。虽然钢板螺丝固定术一直是踝关节融合和骨折修復的传统方法,但髓内钉固定术因其能够提供稳定的对位和较高的骨癒合率而日益受到认可。
由于其疗效可靠且软组织併发症少,髓内钉在关节融合术(用于稳定踝关节以缓解关节炎或严重创伤引起的疼痛)的应用日益普及。使用髓内钉进行关节融合术的正面效果,包括改善负荷分布和减少植入外露,正在加速其推广应用。
踝关节内钉的成长也得益于适应症的扩大、外形设计改进(例如降低钉体高度)以及外科医师训练的加强(尤其註重微创技术)。随着临床成功案例的积累,预计到2031年,踝关节内钉在所有内钉手术中所占的份额将越来越大。
市场限制
竞标竞争
在整形外科创伤市场,尤其是在公共医疗体系涵盖的地区,公共采购和竞标采购正变得越来越普遍。在这些体系下,政府机构或采购集团进行竞争性竞标,製造商主要在价格上竞争。
这种采购模式加剧了价格竞争,对平均售价(ASP)造成了强劲的下行压力,尤其是在中国和西欧等高需求市场。 2021年底中国推出的价值导向采购(VBP)计画进一步加速了这一趋势,导致多个整形外科器械类别的价格大幅下降。
虽然竞标提高了准入门槛和透明度,但也使拥有大规模生产和分销能力的成熟供应商受益,提高了规模较小或专注于特定参与企业的供应商的准入门槛。预计这种定价环境将持续下去,即使手术量持续成长,市场价值成长也会放缓。
在某些创伤病例中,外固定仍然是内固定的有效替代方案。其模组化设计允许在整个癒合过程中进行调整,从而为骨折治疗提供了灵活性。外固定器在开放性骨折和复合性骨折中尤其有用,因为软组织损伤使得即时进行内固定变得困难。
术后可调整对位以及手术的微创性,使得外固定术在特定患者群体和寻求经济高效解决方案的医疗系统中备受青睐。因此,外固定术持续面临激烈的市场竞争,尤其是在新兴市场和资源有限的医院。
钢板和螺丝衝突
儘管髓内钉具有许多临床优势,但钢板螺丝在整形外科固定领域仍是强大的竞争者。解剖型钢板设计、锁定技术和可变角度螺丝系统的进步,扩大了钢板固定的适应症范围。
这些创新使钢板固定係统更加通用且创伤更小,缩小了钢板固定和髓内钉固定在某些类型骨折中的性能差距。在某些情况下,外科医生可能会选择钢板,以便更方便地取出器械或最大限度地减少髓内损伤。
儘管髓内钉在长骨治疗中仍占据主导地位,但钢板螺丝系统的日益复杂化预计将抑制整体市场成长率。
竞争分析
2024年,DePuy Synthes在全球髓内钉市场占据领先地位。该公司主导地位的取得归功于其全面的Advanced Nail System和Expert Nail®产品线,这些产品涵盖所有主要解剖适应症。髓内钉以及钢板和螺丝是DePuy Synthes最主要的收入来源之一。持续投入产品研发和外科医生培训,帮助该公司保持了其全球市场份额,并有望在预测期内进一步巩固其市场地位。
史赛克在全球髓内钉市场占据第二大市场。该公司的T2™髓内钉系统仍然是创伤固定领域最受认可且临床应用最广泛的平台之一。 T2™产品线涵盖多个解剖部位,并采用模组化器材以提高手术效率。史赛克专注于具有竞争力的价格以及持续拓展高成长地区,从而实现了市场份额的稳步增长,预计这一趋势将持续到2031年。
2024年,史密斯医疗(Smith & Nephew)凭藉其用于股骨、肱骨和胫骨骨折的TRIGEN®髓内钉产品线,占据了第三大市场份额。该公司致力于创新,专注于优化形状以分散负荷并最大限度地减少软组织刺激。儘管史密斯医疗的市场份额稳步增长,但来自大型跨国公司的激烈竞争限制了其快速扩张的潜力。
市场和数据覆盖范围
科技与临床趋势
地区
本版内容涵盖全球,包括北美、欧洲、亚太地区、拉丁美洲以及中东和非洲。
74页详细资料和说明分析。
附录简称调查方法。
图表清单
图表列表
调查方法
全球关税的影响
髓内钉市场
The global intramedullary (IM) nail market was valued at $1.2 billion in 2024. The market is projected to grow, reaching $1.5 billion by 2031.
This report covers the full suite of products in the global intramedullary nail market, including humeral, forearm, femoral, tibial, and ankle IM nails. It quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares, and analyzes market drivers, limiters, procedure numbers, recent mergers and acquisitions, and technology trends. The study provides historical data to 2021 and forecasts through 2031.
Market Overview
Intramedullary nails are a cornerstone of orthopedic trauma fixation, particularly in long-bone fracture management. Their ability to provide internal stabilization within the medullary canal allows for early mobilization and improved load sharing compared to traditional plating systems. Over the past decade, IM nails have become the preferred treatment for femoral and tibial fractures, and their use is expanding to the humerus and ankle.
Advances in surgical technique and implant design have positioned IM nails as an essential component of trauma care. Manufacturers continue to refine nail geometry, locking mechanisms, and instrumentation to improve ease of insertion, alignment accuracy, and biomechanical performance. These developments help to reduce operating times, minimize complications, and improve clinical outcomes.
While the IM nail market remains competitive and mature in developed regions, emerging markets are seeing strong volume growth as access to trauma care improves. The global aging population, rising incidence of osteoporosis-related fractures, and increased rates of high-energy injuries from road accidents are supporting procedural demand worldwide.
In addition to trauma repair, limb lengthening and deformity correction represent an emerging growth area. As companies seek to expand beyond traditional fracture fixation, specialized intramedullary systems are being developed for non-trauma indications. These applications leverage IM nail mechanics for controlled distraction osteogenesis and bone realignment, opening new opportunities in orthopedics.
Overall, the IM nail market continues to evolve through incremental design innovation, enhanced instrumentation, and improved materials. These trends are expected to sustain moderate growth in a market defined by strong procedural demand but tempered by pricing pressures and competitive overlap with alternative fixation methods.
Market Drivers
Favorable Clinical Outcomes
Intramedullary nails consistently demonstrate superior biomechanical stability and weight-bearing capacity compared with plates and screws for long-bone fractures. Their load-sharing design enables earlier mobilization, reducing the risk of joint stiffness and muscle atrophy. This characteristic is especially important in femoral and tibial fractures, where early rehabilitation can significantly improve long-term function.
Surgeons often favor IM nails in cases requiring durable fixation, particularly when both axial and torsional stability are critical. Improved postoperative outcomes-such as reduced infection rates, better alignment, and shorter hospital stays-reinforce clinical confidence in IM nail systems. These advantages continue to drive steady adoption across all major anatomical segments.
Instrumentation Improvements
Although the nail constructs themselves are relatively standardized, differentiation among competitors has shifted toward instrumentation design. Modern IM nail systems emphasize ergonomic, intuitive instrumentation that streamlines the surgical workflow.
Manufacturers are investing in targeting devices, reaming tools, and locking mechanisms that improve precision while minimizing radiation exposure and operating time. Simplified targeting guides reduce the risk of malalignment, while integrated depth and angle controls enhance accuracy in screw placement.
Continuous updates to instrumentation systems have become a key factor influencing surgeon preference and brand loyalty. As surgical efficiency increasingly shapes purchasing decisions, companies with comprehensive, user-friendly systems are gaining competitive advantage.
Growth in Ankle Nails
Among all anatomical applications, ankle IM nails represent the fastest-growing segment. Historically, plate and screw fixation dominated ankle arthrodesis and fracture repair; however, IM nails are increasingly recognized for their ability to provide stable alignment and high fusion rates.
Their use in arthrodesis procedures-which fuse the ankle joint to relieve pain from arthritis or severe trauma-has gained traction due to reliable outcomes and reduced soft-tissue complications. The favorable results associated with IM nail arthrodesis, including improved load distribution and reduced hardware prominence, are accelerating adoption.
Growth in ankle nails is further supported by expanded clinical indications, improved designs with lower profiles, and surgeon training initiatives that emphasize minimally invasive techniques. As evidence of clinical success accumulates, ankle nails are expected to account for a growing share of total IM nail procedures through 2031.
Market Limiters
Tender Competition
Public procurement and tender-based purchasing have become increasingly common in the orthopedic trauma market, particularly in regions with publicly funded healthcare systems. Under these systems, government bodies or group purchasing organizations open competitive bids in which manufacturers compete primarily on price.
This procurement model has intensified price competition and exerted strong downward pressure on ASPs, especially in high-volume markets such as China and Western Europe. The introduction of value-based procurement (VBP) programs in China at the end of 2021 further accelerated this trend, causing sharp reductions in pricing across multiple orthopedic device categories.
While tenders improve access and transparency, they also favor established suppliers with large-scale manufacturing and distribution capacity, creating high entry barriers for smaller or niche players. This pricing environment is expected to persist, moderating market value growth even as procedural volumes continue to rise.
External fixation remains a viable alternative to IM nailing in specific trauma cases. Its modular design allows adjustments throughout the healing process, providing flexibility in fracture management. External fixators are particularly useful for open or complex fractures, where soft-tissue damage precludes immediate internal fixation.
The ability to manipulate alignment postoperatively and the reduced surgical invasiveness of external fixation appeal to certain patient populations and healthcare systems seeking cost-effective solutions. As a result, external fixation continues to exert competitive pressure, particularly in emerging markets and resource-constrained hospitals.
Competition from Plates and Screws
Despite the clinical advantages of IM nails, plates and screws remain strong competitors in the orthopedic fixation landscape. Advances in anatomic plate design, locking technology, and variable-angle screw systems have expanded the range of indications treatable with plate fixation.
These innovations have made plating systems more versatile and less invasive, narrowing the performance gap between plate and IM nail fixation for certain fracture types. In some cases, surgeons may choose plates for easier hardware removal or to minimize intramedullary canal disruption.
While IM nails continue to dominate long-bone indications, the growing sophistication of plate and screw systems is expected to limit the market's overall expansion rate.
Competitive Analysis
DePuy Synthes led the global intramedullary nail market in 2024. The company's leadership stems from its comprehensive Advanced Nailing System and Expert Nail(R) product lines, which cover all major anatomical applications. IM nails represent one of DePuy Synthes' strongest revenue contributors alongside plates and screws. Continued investment in product development and surgeon education supports its dominant global share, and the company is expected to strengthen its position further during the forecast period.
Stryker ranked second in the global IM nail market. Its T2(TM) nail system remains one of the most recognized and clinically established platforms in trauma fixation. The T2(TM) line covers multiple anatomical sites and incorporates modular instrumentation designed for surgical efficiency. Stryker's focus on competitive pricing and continued expansion into high-growth regions has allowed it to steadily increase market share, a trend expected to persist through 2031.
Smith & Nephew held the third-largest share in 2024, supported by its TRIGEN(R) family of IM nails for femoral, humeral, and tibial fractures. The company's innovation has centered on optimizing geometry for load sharing and minimizing soft-tissue irritation. While Smith & Nephew achieved incremental gains in share, strong competition from larger multinational firms limits its potential for rapid expansion.
Market Coverage and Data Scope
Technology and Practice Trends
Geography
This edition provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
74 pages of detailed data and narrative analysis.
Methodology Appendix and Acronym Glossary included.
Where are the largest and fastest-growing opportunities within the global intramedullary nail market.
How the shift toward ankle IM nails and limb lengthening applications will shape future market growth.
Which companies lead in innovation, and how their portfolios compare in scope, pricing, and clinical adoption.
How tender-based purchasing and value-based procurement programs influence global pricing dynamics.
What design and instrumentation improvements are driving surgeon preference and brand loyalty.
How IM nails compare with plates, screws, and external fixation systems in terms of cost, outcomes, and versatility.
The Global Intramedullary Nail Market Report from iData Research answers these questions with detailed market models, company share analysis, and ASP benchmarking.
It enables stakeholders to quantify demand, evaluate pricing trends, align product strategy, and identify expansion opportunities across key anatomical and regional segments.
Table Of Contents
List Of Figures
List Of Charts
Research Methodology
Impact Of Global Tariffs
Intramedullary Nail Market